NUELTRA

Serial Number 90690995
606

Registration Progress

Application Filed
May 5, 2021
Under Examination
Apr 12, 2022
Approved for Publication
Feb 15, 2022
Published for Opposition
Feb 15, 2022
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NUELTRA
Previous Owner: Azurity Pharmaceuticals, Inc.
Classes: 005

Trademark Image

NUELTRA

Basic Information

Serial Number
90690995
Filing Date
May 5, 2021
Published for Opposition
February 15, 2022
Abandonment Date
May 15, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 15, 2023
Classes
005

Rights Holder

Azurity Pharmaceuticals, Inc.

03
Address
8 Cabot Road, Suite 2000
Woburn, MA 01801

Ownership History

Azurity Pharmaceuticals, Inc.

Original Applicant
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Owner at Publication
03
Woburn, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

13 events
Date Code Type Description Documents
May 15, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 15, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 27, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 25, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 25, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 12, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 10, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 7, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 6, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical formulations and compositions containing topiramate; pharmaceutical preparations for the preventative treatment of seizures or migraines; anticonvulsants

Classification

International Classes
005